Yongqian Wu
Founder, CEO & ChairmanDr. Yongqian Wu, alos known as Frank, Ph.D is a Founder at TransThera Sciences (Nanjing), Inc. (formerly known as Nanjing TransThera Biosciences Co. Ltd.) and serves as its Chief Executive Officer and Chairman of the Board since November 18, 2016 and serves as its Director since May 10, 2016. He joined TransThera Sciences (Nanjing), Inc. on June 10, 2016 and has been participating in the daily operations since then. Prior to joining TransThera, Dr. Wu joined Sihuan Pharmaceutical Holdings Group Ltd., a comprehensive pharmaceutical company engaged in R&D, manufacture and sales of medicine listed on the Main Board of the Stock Exchange (?Sihuan Pharmaceutical?) in 2011. Dr. Wu served as the senior vice president of project management of Shandong Xuanzhu Biopharmaceutical Co., Ltd. (?Shandong Xuanzhu Biopharmaceutical?), a wholly owned subsidiary of Sihuan Pharmaceutical, from January 2011 to December 2012 and as the general manager Shandong Xuanzhu Biopharmaceutical from January 2013 to May 2016, where he was primarily responsible for the overall management and operations of the company. He was the chief scientific officer of Sihuan Pharmaceutical from 2014 to 2015. He also worked for five years at Boehringer Ingelheim Pharmaceuticals Inc., where he was responsible for the research projects in immunology and cardiovascular drug. Moreover, he was employed by Guilford Pharmaceuticals, Inc. from November 1996 to June 2005. Dr. Wu has been granted several certificates and recognitions in the industry and the community. He was a member of prestigious American Chemistry Society Division of Medicinal Chemistry long range planning committee from 2008 to 2010. He was appointed as an editor of Chinese Journal of New Drugs in 2014 and an editor of Progress in Pharmaceutical Sciences in 2020. He was a member of the first session (years 2015-2019) of the ?Drug Development Committee? of the China Pharmaceutical Innovation and Research Development Association. He was a visiting professor at the School of Pharmacy of Sun Yat-sen University from May 2014 to May 2017. Dr. Wu obtained his bachelor?s degree in chemistry from Nanjing University in the PRC in July 1985. He further obtained his doctor?s degree in philosophy from Wayne State University in the U.S. in May 1993 and was appointed as a postdoctoral fellow in the biochemistry department from Brandeis University in the U.S. from January 1994 to December 1995.
Positions
- Company NameTransThera Sciences (Nanjing), Inc.Stock Code02617PositionFounder, CEO & ChairmanColleagues
- DWDi WuPresident, Financial Controller & Executive Director
- DSDelong SunChief Operating Officer
- SCSongxi CuiVice President of Operations
- JFJing FanChief Medical Officer
- SPShu Pai LiIndependent Non-Executive Director
- HYHoi Yam ChuiIndependent Non-Executive Director
- WZWeili ZhaoEmployees Representative Chairwoman of Supervisory Board
